MCID: URT001
MIFTS: 48

Urethritis

Categories: Nephrological diseases

Aliases & Classifications for Urethritis

MalaCards integrated aliases for Urethritis:

Name: Urethritis 12 43 15 17 71
Non-Gonococcal Urethritis 12 71
Nongonococcal Urethritis 12 54
Nonspecific Urethritis 71 32

Classifications:



External Ids:

Disease Ontology 12 DOID:1343
ICD9CM 34 597.80
MeSH 43 D014526
NCIt 49 C26904
SNOMED-CT 67 31822004
UMLS 71 C0041976 C0311389 C1112709

Summaries for Urethritis

MalaCards based summary : Urethritis, also known as non-gonococcal urethritis, is related to urethral syndrome and transverse myelitis. An important gene associated with Urethritis is DEFB4A (Defensin Beta 4A), and among its related pathways/superpathways are Human cytomegalovirus infection and Allograft rejection. The drugs Doxycycline and Lymecycline have been mentioned in the context of this disorder. Affiliated tissues include prostate, testes and kidney.

Wikipedia : 74 Urethritis is inflammation of the urethra. The most common symptom is painful or difficult urination. It... more...

Related Diseases for Urethritis

Diseases related to Urethritis via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 1157, show less)
# Related Disease Score Top Affiliating Genes
1 urethral syndrome 33.5 MTRR MT-TG MRAP KLK3 IL6 GPR182
2 transverse myelitis 32.3 TNF IL6 CXCL8
3 spinal cord injury 31.2 TNF IL6 CXCL8
4 syphilis 30.9 MRAP CRP CD40LG CD4
5 conjunctivitis 30.8 TNF IL6 CXCL8
6 prostatitis 30.8 TNF KLK3 IL6 CXCL8
7 reactive arthritis 30.7 TNF TLR4 TLR2 IL6 HSPD1 CXCL8
8 chancroid 30.6 HSPD1 CD40LG CD4
9 haemophilus influenzae 30.6 TNF TLR2 CXCL8
10 primary syphilis 30.4 CD40LG CD4
11 pyuria 30.3 KLK3 IL6 CXCL8 CRP CD40LG
12 latent syphilis 30.3 CD40LG CD4
13 intussusception 30.3 IL6 CRP CD40LG
14 ornithosis 30.3 NAT9 ESCO2 CD40LG
15 trichomoniasis 30.3 TNF IL6 CXCL8 CD40LG CD4
16 proctitis 30.2 TNF KLK3 CRP
17 cystitis 30.2 TNF TLR4 IL6 CXCL8 CRP
18 endocervicitis 30.2 MT-TG ESCO2
19 microsporidiosis 30.2 DEFB4A DEFA5 CD4
20 acute pyelonephritis 30.2 IL6 CXCL8 CRP
21 trachoma 30.2 TNF IL6 HSPD1
22 necrotizing fasciitis 30.1 IL6 CXCL8 CRP
23 inclusion conjunctivitis 30.1 NAT9 HSPD1 ESCO2 CD40LG
24 acute gonococcal cervicitis 30.1 VDAC1 MT-TG
25 amyloidosis 30.1 TNF IL6 CRP CD40LG
26 vaginal discharge 30.1 IL6 CXCL8 CRP CD40LG CD4
27 cervicitis 30.1 TLR4 TLR2 NAT9 MT-TG MRAP IL6
28 fasciitis 30.1 TNF IL6 CXCL8
29 anogenital venereal wart 30.0 TLR4 TLR2 CD4
30 diverticulitis 30.0 TNF IL6 CRP
31 orchitis 30.0 TNF IL6 CRP CD40LG CD4
32 cardiomyopathy, familial hypertrophic, 20 30.0 IL6 CXCL8 CD4
33 pleural empyema 30.0 CRP CD40LG CD4
34 ophthalmia neonatorum 29.9 NAT9 MTRR MAP10 GPR182
35 combined t cell and b cell immunodeficiency 29.9 IL6 CD40LG CD4
36 acute transverse myelitis 29.9 IL6 CXCL8
37 varicose veins 29.9 TNF IL6 CXCL8
38 chlamydia 29.9 TNF TLR4 TLR2 IL6 HSPD1 CXCL8
39 autoimmune pancreatitis 29.9 TNF CD40LG CD4
40 suppression of tumorigenicity 12 29.8 KLK3 IL6 CXCL8 CD4
41 decubitus ulcer 29.8 TNF IL6 CRP
42 optic papillitis 29.8 MRAP CRP CD40LG CD4
43 pyelonephritis 29.8 TNF TLR4 IL6 CXCL8 CRP
44 myelitis 29.8 TNF IL6 CXCL8 CD40LG
45 bacteriuria 29.7 TLR4 TLR2 IL6 CXCL8 CRP CD40LG
46 pulmonary edema 29.7 TNF CXCL8 CRP
47 lichen planus 29.7 TNF IL6 DEFB4A CXCL8
48 spinal cord disease 29.7 TNF IL6 CD40LG CD4
49 neurofibromatosis, type ii 29.7 TNF TLR2 IL6 DEFB4A CXCL8
50 irritant dermatitis 29.6 TNF IL6 CXCL8
51 cellulitis 29.6 TNF IL6 DEFB4A CRP CD40LG CD4
52 compartment syndrome 29.6 TNF IL6 CRP
53 severe cutaneous adverse reaction 29.6 TNF CRP CD40LG CD4
54 erythema multiforme 29.6 TNF IL6 CXCL8
55 urticaria 29.6 TNF IL6 CRP CD40LG
56 fibromyalgia 29.5 TNF IL6 CXCL8 CRP
57 spondylitis 29.5 TNF IL6 CRP
58 pericardial effusion 29.5 IL6 CRP CD40LG CD4
59 iron deficiency anemia 29.5 TNF IL6 CRP
60 respiratory failure 29.5 TNF IL6 CXCL8 CRP CD4
61 acquired immunodeficiency syndrome 29.4 TNF IL6 CRP CD40LG CD4
62 sarcoidosis 1 29.4 TNF MRAP CRP CD40LG CD4
63 cerebral palsy 29.4 TNF TLR4 IL6 CXCL8
64 synovitis 29.4 TNF IL6 CXCL8 CRP
65 pelvic inflammatory disease 29.3 TLR4 TLR2 NAT9 HSPD1 ESCO2 CRP
66 diarrhea 29.3 TNF TLR4 IL6 CXCL8 CD40LG
67 myelofibrosis 29.3 TNF CXCL8 CRP CD40LG
68 placenta disease 29.3 TNF IL6 CXCL8 CRP
69 gastroenteritis 29.3 TNF IL6 CXCL8 CRP
70 encephalomalacia 29.3 TLR4 IL6 CRP
71 disseminated intravascular coagulation 29.3 TNF IL6 CRP
72 leptin deficiency or dysfunction 29.2 TNF IL6 CRP
73 herpes zoster 29.2 TNF TLR2 CRP CD40LG CD4
74 vasculitis 29.2 TNF IL6 HSPD1 CRP CD40LG
75 osteomyelitis 29.2 TNF TLR4 TLR2 IL6 CXCL8
76 tenosynovitis 29.2 TNF MRAP IL6 CRP CD40LG
77 endocarditis 29.2 TNF TLR2 IL6 HSPD1 CXCL8 CRP
78 chickenpox 29.1 TNF IL6 CRP CD40LG CD4
79 migraine with or without aura 1 29.1 TNF IL6 CRP CD40LG
80 autoimmune disease 29.1 TNF IL6 HSPD1 CXCL8 CRP CD40LG
81 vaginitis 29.1 TNF TLR4 TLR2 IL6 DEFB4A CXCL8
82 arthritis 29.0 TNF TLR4 TLR2 IL6 CXCL8 CRP
83 dermatitis 29.0 TNF TLR4 TLR2 IL6 CXCL8
84 lymphoma, mucosa-associated lymphoid type 29.0 TLR4 TLR2 HSPD1 CD40LG CD4
85 allergic hypersensitivity disease 29.0 TNF TLR4 TLR2 CXCL8 CD4
86 arteriosclerosis 29.0 TLR4 IL6 HSPD1 CRP
87 acute cystitis 29.0 TNF TLR4 TLR2 KLK3 IL6 GPR182
88 septic arthritis 29.0 TLR4 TLR2 MRAP DEFB4A CXCL8 CRP
89 granulomatosis with polyangiitis 29.0 TNF TLR4 TLR2 CRP CD40LG CD4
90 bacterial vaginosis 28.9 TNF TLR4 TLR2 IL6 DEFB4A DEFA5
91 endometritis 28.9 TNF TLR4 TLR2 IL6 CXCL8
92 iritis 28.9 TNF MRAP IL6 CRP CD40LG CD4
93 iridocyclitis 28.9 TNF MRAP IL6 CRP CD40LG CD4
94 pharyngitis 28.8 TNF IL6 CXCL8 CRP CD40LG CD4
95 candidiasis 28.8 TNF TLR4 TLR2 IL6 DEFB4A CXCL8
96 mycobacterium tuberculosis 1 28.8 TNF TLR4 TLR2 HSPD1 CRP CD4
97 peritonitis 28.7 TNF TLR4 TLR2 IL6 CXCL8 CRP
98 salpingitis 28.7 VDAC1 TNF TLR2 NAT9 HSPD1 ESCO2
99 chorioamnionitis 28.6 TNF TLR4 IL6 CXCL8 CRP
100 cerebrovascular disease 28.6 TNF TLR4 IL6 CRP CD40LG
101 neuromuscular disease 28.6 TNF IL6 CD40LG CD4
102 ulcerative colitis 28.6 TNF TLR4 IL6 CXCL8 CRP
103 echinococcosis 28.6 TNF TLR4 TLR2 IL6 CD40LG
104 measles 28.6 TNF TLR4 TLR2 IL6 CD40LG
105 irritable bowel syndrome 28.6 TNF TLR4 TLR2 IL6 CXCL8
106 amebiasis 28.5 TNF TLR4 TLR2 CXCL8 CD40LG CD4
107 crohn's disease 28.5 TNF TLR4 TLR2 IL6 DEFA5 CXCL8
108 stomatitis 28.5 TNF TLR4 TLR2 IL6 CXCL8 CD40LG
109 endophthalmitis 28.5 TNF TLR2 MRAP IL6 CXCL8 CRP
110 vascular disease 28.4 TNF TLR4 MTRR IL6 HSPD1 CRP
111 colitis 28.4 TNF TLR4 TLR2 IL6 DEFA5 CXCL8
112 meningitis 28.3 TNF TLR4 TLR2 IL6 CXCL8 CRP
113 contact dermatitis 28.3 TNF TLR4 TLR2 IL6 CXCL8 CD4
114 chagas disease 28.3 TNF TLR4 TLR2 IL6 CXCL8 CD4
115 multiple sclerosis 28.2 TNF TLR4 TLR2 IL6 HSPD1 CXCL8
116 toxic shock syndrome 28.2 TNF TLR4 TLR2 IL6 HSPD1 CXCL8
117 myeloma, multiple 28.1 TNF TLR4 IL6 CXCL8 CRP CD40LG
118 peripheral nervous system disease 28.0 TNF TLR4 TLR2 IL6 CXCL8 CRP
119 pyelitis 28.0 TNF TLR4 TLR2 IL6 CXCL8 CRP
120 bacterial infectious disease 27.9 TNF TLR4 TLR2 IL6 HSPD1 DEFB4A
121 heart disease 27.9 TNF TLR4 IL6 CXCL8 CRP CD40LG
122 thrombocytopenia 27.9 TNF TLR4 TLR2 IL6 CXCL8 CRP
123 body mass index quantitative trait locus 11 27.8 TNF TLR4 TLR2 IL6 CXCL8 CRP
124 skin disease 27.8 TNF TLR4 TLR2 IL6 DEFB4A CXCL8
125 bone inflammation disease 27.8 TNF TLR4 TLR2 MRAP IL6 CXCL8
126 leprosy 3 27.8 TNF TLR4 TLR2 IL6 HSPD1 CXCL8
127 lymph node disease 27.8 TNF TLR4 TLR2 IL6 HSPD1 CRP
128 diabetes mellitus 27.7 TNF TLR4 TLR2 IL6 HSPD1 CXCL8
129 dysentery 27.7 TNF TLR4 TLR2 IL6 GPR182 CXCL8
130 urethral stricture 12.8
131 urethral diverticulum 12.7
132 urethral cancer 12.5
133 posterior urethral valves 12.5
134 urethral gland abscess 12.4
135 urethral benign neoplasm 12.4
136 urethral calculus 12.3
137 urethral obstruction sequence 12.3
138 female urethral cancer 12.3
139 male urethral cancer 12.3
140 urethral villous adenoma 12.3
141 cervical ribs, sprengel anomaly, anal atresia, and urethral obstruction 12.3
142 urethral intrinsic sphincter deficiency 12.3
143 urethral false passage 12.3
144 anterior urethral valve 12.2
145 vitiligo, progressive, with mental retardation and urethral duplication 12.2
146 penile urethral cancer 12.2
147 bulbomembranous urethral cancer 12.2
148 infective urethral stricture 12.1
149 urethral urothelial papilloma 12.1
150 urethral verrucous carcinoma 12.1
151 prostatic urethral cancer 12.1
152 duplication of urethra 12.1
153 lower urinary tract obstruction, congenital 12.1
154 fowler urethral sphincter dysfunction syndrome 12.1
155 posterior urethra cancer 12.0
156 urethra leiomyoma 11.9
157 hypospadias 11.8
158 anterior urethra cancer 11.8
159 exstrophy of bladder 11.7
160 atresia of urethra 11.6
161 urethra squamous cell carcinoma 11.6
162 urethra transitional cell carcinoma 11.5
163 urethra cancer 11.5
164 urethra adenocarcinoma 11.5
165 cakut 11.4
166 meningococcal infection 11.4
167 congenital anomalies of kidney and urinary tract 2 11.4
168 prostate embryonal rhabdomyosarcoma 11.4
169 fibroepithelial polyp of urethra 11.4
170 urethra clear cell adenocarcinoma 11.4
171 hypospadias 1, x-linked 11.3
172 vacterl association, x-linked, with or without hydrocephalus 11.3
173 congenital anomalies of kidney and urinary tract 1 11.3
174 mucoepithelial dysplasia, hereditary 11.1
175 mckusick-kaufman syndrome 11.1
176 testicular regression syndrome 11.1
177 hypospadias 2, x-linked 11.1
178 pigmentary disorder, reticulate, with systemic manifestations, x-linked 11.1
179 otopalatodigital syndrome, type ii 11.1
180 mirage syndrome 11.1
181 congenital anomalies of kidney and urinary tract 3 11.1
182 dyskeratosis congenita 11.1
183 proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome 11.1
184 urethra inverted papilloma 11.1
185 impotence 10.8
186 prostatic hypertrophy 10.8
187 prostatic adenoma 10.7
188 urinary tract obstruction 10.7
189 prostatic hyperplasia, benign 10.7
190 vesicoureteral reflux 1 10.7
191 hydronephrosis 10.7
192 bladder cancer 10.6
193 transitional cell carcinoma 10.6
194 adenocarcinoma 10.6
195 lichen sclerosus et atrophicus 10.6
196 neurogenic bladder 10.6
197 end stage renal failure 10.6
198 riedel's fibrosing thyroiditis 10.5 CD40LG CD4
199 detrusor sphincter dyssynergia 10.5
200 mycobacterium fortuitum 10.5 HSPD1 CXCL8
201 pelvic organ prolapse 10.5
202 low compliance bladder 10.5
203 cork-handlers' disease 10.5 CD40LG CD4
204 syphilitic meningitis 10.5 CD40LG CD4
205 oligohydramnios 10.5
206 renal dysplasia 10.5
207 specific bursitis often of occupational origin 10.5 MRAP CRP
208 glossopharyngeal nerve paralysis 10.5 KLK3 CD40LG
209 leiomyoma 10.5
210 adenoma 10.5
211 in situ carcinoma 10.4
212 anterior scleritis 10.4 MRAP CRP
213 olecranon bursitis 10.4 MRAP CRP
214 juvenile ankylosing spondylitis 10.4 TNF MRAP
215 early yaws 10.4 CD40LG CD4
216 transient arthritis 10.4 MRAP CD40LG CD4
217 hemangioma 10.4
218 acute retinal necrosis syndrome 10.4 MRAP CD40LG CD4
219 orbital plasma cell granuloma 10.4 CRP CD40LG
220 whipple disease 10.4 MRAP HSPD1 CRP
221 prune belly syndrome 10.4
222 mycobacterium chelonae 10.4 TLR2 CXCL8
223 drug reaction with eosinophilia and systemic symptoms 10.4 TNF CRP
224 balanitis 10.4
225 kidney disease 10.4
226 47,xyy 10.4
227 ehrlichiosis 10.4 HSPD1 CD40LG CD4
228 japanese spotted fever 10.4 HSPD1 CRP CD40LG
229 diabetes mellitus, insulin-dependent, 23 10.4 TNF CD4
230 gastroduodenitis 10.4 CD40LG CD4
231 chronic orbital inflammation 10.4 MRAP CRP CD40LG
232 mycobacterium marinum 10.4 TLR2 CXCL8
233 prostate cancer 10.4
234 herpes simplex 10.4
235 cervical adenitis 10.4 HSPD1 CRP CD40LG
236 granuloma inguinale 10.4 NAT9 ESCO2 CD4
237 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.4
238 asymptomatic neurosyphilis 10.4 CD40LG CD4
239 toxocariasis 10.4 MRAP CRP CD40LG
240 ross river fever 10.4 NAT9 CD40LG
241 oral candidiasis 10.4 DEFB4A CXCL8 CD4
242 mycobacterium kansasii 10.4 TLR2 CXCL8
243 clear cell adenocarcinoma 10.4
244 rheumatoid arthritis interstitial lung disease 10.4 TNF CRP
245 vulvovaginal candidiasis 10.4 TLR2 DEFB4A DEFA5
246 pericardial tuberculosis 10.4 CRP CD4
247 tertiary syphilis 10.3 CRP CD40LG CD4
248 granulomatous hepatitis 10.3 CRP CD40LG CD4
249 macs syndrome 10.3 TNF HSPD1 CD4
250 anus, imperforate 10.3
251 mononeuritis of upper limb and mononeuritis multiplex 10.3 CRP CD40LG CD4
252 mononeuritis multiplex 10.3 CRP CD40LG CD4
253 cerebritis 10.3 CRP CD40LG CD4
254 parotid disease 10.3 CRP CD40LG CD4
255 squamous cell carcinoma 10.3
256 erythema elevatum diutinum 10.3 CXCL8 CD40LG
257 chronic meningitis 10.3 CRP CD40LG CD4
258 parotitis 10.3 CRP CD40LG CD4
259 duodenitis 10.3 CRP CD40LG CD4
260 xerophthalmia 10.3 CRP CD40LG CD4
261 cranial nerve palsy 10.3 CRP CD40LG CD4
262 balanitis xerotica obliterans 10.3
263 infertility 10.3
264 leukoplakia of penis 10.3
265 papilledema 10.3 CRP CD40LG CD4
266 facial paralysis 10.3 CRP CD40LG CD4
267 facial nerve disease 10.3 CRP CD40LG CD4
268 pustulosis of palm and sole 10.3 TNF MRAP CXCL8
269 posterior scleritis 10.3 TNF MRAP CRP
270 scleritis 10.3 TNF MRAP CRP
271 external pathological resorption 10.3 TNF IL6
272 drug allergy 10.3 CRP CD40LG CD4
273 osteosclerotic myeloma 10.3 IL6 CD40LG
274 neurosyphilis 10.3 TLR2 CXCL8
275 bladder neck obstruction 10.3
276 multidrug-resistant tuberculosis 10.3 TNF GPR182 CD4
277 acute gonococcal endometritis 10.3 VDAC1 CD40LG
278 granulomatous dermatitis 10.3 TNF CD40LG CD4
279 bladder urothelial carcinoma 10.3
280 chondromalacia 10.3 TNF MRAP CRP
281 blastomycosis 10.3 TNF CD40LG CD4
282 bursitis 10.3 TNF MRAP CRP
283 scorpion envenomation 10.3 TNF IL6
284 sporotrichosis 10.3 TNF CD40LG CD4
285 uveoparotid fever 10.3 TNF CD40LG CD4
286 crohn's colitis 10.3 TNF DEFA5 CXCL8
287 intestinal tuberculosis 10.3 TNF CRP CD4
288 enthesopathy 10.3 TNF MRAP CRP
289 sexual disorder 10.3
290 interstitial cystitis 10.3
291 48,xyyy 10.3
292 autoimmune disease of peripheral nervous system 10.3 TNF CD40LG CD4
293 relapsing fever 10.3 TNF HSPD1 CRP
294 cold agglutinin disease 10.3 IL6 CRP
295 tertiary neurosyphilis 10.3 CD40LG CD4
296 histoplasmosis 10.3 TNF CD40LG CD4
297 toxicodendron dermatitis 10.3 TNF CXCL8
298 neurosarcoidosis 10.3 TNF CRP CD4
299 nephrogenic adenoma 10.3
300 chronic kidney disease 10.3
301 cardiogenic shock 10.3 IL6 CRP
302 cryopyrin-associated periodic syndrome 10.3 IL6 CRP
303 poliomyelitis 10.3 TNF CD40LG CD4
304 seborrheic dermatitis 10.3 TNF CXCL8 CD4
305 lymphogranuloma venereum 10.3
306 progressive multifocal leukoencephalopathy 10.3 TNF CD40LG CD4
307 pleural tuberculosis 10.3 TNF CXCL8 CD4
308 nasopharyngitis 10.3 TNF CRP CD4
309 scarlet fever 10.3 TNF CRP CD40LG
310 angioimmunoblastic lymphadenopathy with dysproteinemia 10.3 TNF IL6
311 denture stomatitis 10.3 IL6 DEFB4A CXCL8
312 melanoma 10.3
313 paraplegia 10.3
314 fournier gangrene 10.3
315 mononeuropathy 10.2 TNF CRP CD40LG
316 uremic pruritus 10.2 IL6 CRP
317 norwegian scabies 10.2 CD40LG CD4
318 fuchs' heterochromic uveitis 10.2 MRAP IL6 CXCL8
319 cardiac rupture 10.2 TNF CXCL8 CRP
320 systemic autoimmune disease 10.2 IL6 CRP
321 ankylosis 10.2 TNF MRAP CRP
322 pleuropneumonia 10.2
323 salivary gland disease 10.2 TNF CD40LG CD4
324 danubian endemic familial nephropathy 10.2 TNF CRP CD40LG
325 cat-scratch disease 10.2 HSPD1 CRP CD40LG CD4
326 dermatitis herpetiformis 10.2 TNF CXCL8 CD40LG
327 churg-strauss syndrome 10.2 TNF CXCL8 CD40LG
328 bartonellosis 10.2 HSPD1 CRP CD40LG CD4
329 neuroretinitis 10.2 MRAP CRP CD40LG CD4
330 aseptic meningitis 10.2 TNF CXCL8 CD40LG
331 ureterocele 10.2
332 squamous cell papilloma 10.2
333 papilloma 10.2
334 tuberculous epididymitis 10.2 TNF KLK3 CRP
335 spinal disease 10.2 MRAP IL6 CRP
336 neural tube defects 10.2
337 renal hypodysplasia/aplasia 1 10.2
338 cryptorchidism, unilateral or bilateral 10.2
339 body mass index quantitative trait locus 1 10.2
340 genital herpes 10.2
341 epididymo-orchitis 10.2
342 legionnaire disease 10.2 TLR2 CRP CD40LG
343 peptic ulcer disease 10.2 TNF DEFB4A DEFA5 CXCL8
344 lepromatous leprosy 10.2 TNF TLR2 HSPD1
345 mycobacterium abscessus 10.2 TNF TLR2 CXCL8
346 autoimmune disease of blood 10.2 IL6 CD40LG CD4
347 myelomeningocele 10.2
348 penile cancer 10.2
349 phimosis 10.2
350 anuria 10.2
351 malignant tumor of penis 10.2
352 pyoderma 10.2 TNF CXCL8 CRP
353 choroiditis 10.2 TNF MRAP CD40LG CD4
354 tuberculous meningitis 10.2 TNF TLR2 CXCL8
355 female stress incontinence 10.2
356 priapism 10.2
357 patent urachus 10.2
358 acute myocarditis 10.2 IL6 CRP CD4
359 carotid stenosis 10.2 TNF CXCL8 CRP
360 intermediate uveitis 10.2 TNF MRAP IL6
361 opportunistic bacterial infectious disease 10.2 TNF HSPD1 CRP CD4
362 cowpox 10.2 IL6 CXCL8 CD4
363 nocardiosis 10.2 TNF HSPD1 CRP CD4
364 multicentric castleman disease 10.2 IL6 CRP CD4
365 skin sarcoidosis 10.2 TNF CD4
366 autoimmune disease of cardiovascular system 10.1 TNF IL6 CD4
367 acute kidney failure 10.1
368 rhabdomyosarcoma 10.1
369 ureteral obstruction 10.1
370 spasticity 10.1
371 posterior uveitis 10.1 TNF MRAP IL6
372 aspiration pneumonia 10.1 IL6 CRP CD40LG
373 pulmonary artery disease 10.1 IL6 CRP CD40LG
374 funisitis 10.1 IL6 CXCL8 CRP
375 idiopathic anterior uveitis 10.1 TNF IL6 CXCL8
376 streptococcal toxic-shock syndrome 10.1 TNF IL6 CXCL8
377 pouchitis 10.1 TLR4 CXCL8
378 african tick-bite fever 10.1 TNF IL6 CD40LG
379 autoimmune disease of eyes, ear, nose and throat 10.1 TNF IL6 CD4
380 relapsing polychondritis 10.1 IL6 CXCL8 CRP
381 breast abscess 10.1 CRP CD4
382 coccidioidomycosis 10.1 TLR4 CD40LG CD4
383 neuritis 10.1 TNF IL6 CXCL8
384 autoimmune gastritis 10.1 TNF IL6 CD4
385 acute cervicitis 10.1 VDAC1 TLR2 MT-TG
386 castleman disease 10.1 IL6 CXCL8 CRP
387 fibrosis of extraocular muscles, congenital, 1 10.1
388 metabolic acidosis 10.1
389 bladder exstrophy-epispadias-cloacal exstrophy complex 10.1
390 rectum cancer 10.1
391 uremia 10.1
392 pik3ca-related overgrowth syndrome 10.1
393 rare tumor 10.1
394 nail disease 10.1 TNF IL6 CD4
395 meningovascular neurosyphilis 10.1 CD40LG CD4
396 bagassosis 10.1 TNF IL6 CXCL8
397 intermittent claudication 10.1 IL6 CRP CD40LG
398 gastrointestinal tuberculosis 10.1 TNF CRP CD40LG CD4
399 abdominal tuberculosis 10.1 TNF CRP CD40LG CD4
400 good syndrome 10.1 TNF CRP CD40LG CD4
401 miliary tuberculosis 10.1 TNF CRP CD40LG CD4
402 meconium aspiration syndrome 10.1 TNF IL6 CXCL8
403 acute proliferative glomerulonephritis 10.1 TNF CRP CD40LG CD4
404 vitreous disease 10.1 TNF IL6 CXCL8
405 bladder diverticulum 10.1
406 down syndrome 10.1
407 anal fistula 10.1
408 chronic pyelonephritis 10.1
409 sarcoma 10.1
410 prolapse of urethra 10.1
411 rhinosporidiosis 10.1
412 teratoma 10.1
413 spindle cell sarcoma 10.1
414 neuropathy 10.1
415 drug-induced lupus erythematosus 10.1 TNF IL6 CXCL8
416 monoclonal gammopathy of uncertain significance 10.1 TNF IL6 CD40LG
417 dengue shock syndrome 10.1 TNF IL6 CD40LG
418 pulpitis 10.1 TNF IL6 CXCL8
419 subacute thyroiditis 10.1 TNF IL6 CRP
420 yellow fever 10.1 IL6 CRP CD40LG
421 chronic recurrent multifocal osteomyelitis 10.1 TNF IL6 CRP
422 taeniasis 10.1 TLR4 CD40LG CD4
423 plasmodium vivax malaria 10.1 TNF IL6 CD40LG
424 cutaneous lupus erythematosus 10.1 TNF IL6 CD40LG
425 cryptogenic organizing pneumonia 10.1 TNF CXCL8 CRP CD4
426 cryoglobulinemia 10.1 TNF IL6 CD40LG
427 mature b-cell neoplasm 10.1 IL6 CD40LG CD4
428 ischemic bone disease 10.1 TNF IL6 CRP
429 chronic ulcer of skin 10.1 TNF IL6 CRP
430 lens disease 10.1 TNF MRAP IL6
431 pain agnosia 10.1
432 chronic cystitis 10.1
433 endometriosis 10.1
434 mucinous adenocarcinoma 10.1
435 appendix adenocarcinoma 10.1
436 prostate disease 10.1
437 cavernous hemangioma 10.1
438 posterior hypospadias 10.1
439 overgrowth syndrome 10.1
440 cryptosporidiosis 10.1 TLR4 CD40LG CD4
441 hypopyon 10.1 MRAP IL6 CRP CD4
442 bacterial conjunctivitis 10.1 NAT9 MTRR GPR182 CRP CD40LG
443 cytomegalovirus infection 10.1 TNF IL6 CXCL8
444 complex regional pain syndrome 10.1 TNF IL6 CXCL8
445 prediabetes syndrome 10.1 TNF IL6 CRP
446 pulmonary alveolar proteinosis 10.1 TNF IL6 CXCL8
447 antiphospholipid syndrome 10.1 TNF CRP CD40LG
448 keratoconjunctivitis 10.0 TNF IL6 CXCL8
449 gastric ulcer 10.0 TNF IL6 CXCL8
450 lymphocytic choriomeningitis 10.0 TLR2 IL6 CXCL8
451 endocrine pancreas disease 10.0 TNF IL6 CRP
452 systolic heart failure 10.0 TNF IL6 CRP
453 colorectal cancer 10.0
454 renal hypoplasia 10.0
455 quadriplegia 10.0
456 diphallia 10.0
457 malakoplakia 10.0
458 chronic pain 10.0
459 hypertonia 10.0
460 null-cell leukemia 10.0 TNF IL6
461 toxic encephalopathy 10.0 TNF MRAP IL6
462 pneumoconiosis 10.0 TNF IL6 CXCL8
463 uveitis 10.0 TNF IL6 HSPD1 CXCL8
464 fungal keratitis 10.0 TLR4 TLR2
465 polyclonal hypergammaglobulinemia 10.0 IL6 CRP CD40LG CD4
466 sleep disorder 10.0 TNF IL6 CRP
467 ileus 10.0 TNF IL6 CRP
468 avian influenza 10.0 TNF IL6 CXCL8
469 mixed connective tissue disease 10.0 TNF IL6 HSPD1 CD40LG
470 plasma protein metabolism disease 10.0 IL6 CRP CD40LG CD4
471 superficial basal cell carcinoma 10.0 TLR4 TLR2 CD4
472 esophagitis 10.0 TNF IL6 CXCL8
473 pneumonic plague 10.0 TLR4 TLR2 CD4
474 extrapulmonary tuberculosis 10.0 TNF TLR2 CRP CD4
475 peripheral artery disease 10.0 TNF IL6 CRP
476 cranial nerve disease 10.0 IL6 CRP CD40LG CD4
477 nephrolithiasis, calcium oxalate 10.0
478 schistosoma mansoni infection, susceptibility/ 10.0
479 polydactyly 10.0
480 human immunodeficiency virus type 1 10.0
481 muscle hypertrophy 10.0
482 leukemia, acute lymphoblastic 3 10.0
483 inguinal hernia 10.0
484 hydrocephalus 10.0
485 male infertility 10.0
486 trigonitis 10.0
487 amenorrhea 10.0
488 schistosomiasis 10.0
489 vacterl association 10.0
490 lymphangioma 10.0
491 pneumothorax 10.0
492 vulvovaginitis 10.0
493 bladder disease 10.0
494 leukorrhea 10.0
495 horseshoe kidney 10.0
496 leukoplakia 10.0
497 penoscrotal transposition 10.0
498 back pain 10.0
499 rare lymphatic malformation 10.0
500 macular retinal edema 10.0 TNF MRAP IL6 CXCL8
501 fabry disease 10.0 TNF IL6 CRP
502 filarial elephantiasis 10.0 TLR4 TLR2 CD4
503 rheumatic heart disease 10.0 TNF TLR2 IL6
504 fungal meningitis 10.0 TNF IL6 CD40LG CD4
505 tendinitis 10.0 TNF MRAP IL6 CRP
506 childhood type dermatomyositis 10.0 TNF IL6 CD40LG CD4
507 viral meningitis 10.0 IL6 CXCL8 CRP CD40LG
508 autoimmune disease of urogenital tract 10.0 TNF IL6 CD40LG CD4
509 autoimmune disease of endocrine system 10.0 TNF IL6 CD40LG CD4
510 non-alcoholic steatohepatitis 10.0 TNF IL6
511 hair disease 10.0 TNF IL6 CD40LG CD4
512 atrophic gastritis 10.0 TNF IL6 CXCL8
513 chronic conjunctivitis 10.0 TNF IL6 CXCL8 CD4
514 blepharitis 10.0 TNF IL6 CXCL8 CD4
515 pancytopenia 10.0 IL6 CRP CD40LG CD4
516 cardiomyopathy, familial hypertrophic, 2 9.9
517 hair whorl 9.9
518 multiple system atrophy 1 9.9
519 mayer-rokitansky-kuster-hauser syndrome 9.9
520 hydrops, lactic acidosis, and sideroblastic anemia 9.9
521 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 9.9
522 gastrointestinal ulceration, recurrent, with dysfunctional platelets 9.9
523 angiosarcoma 9.9
524 hyperphosphatemia 9.9
525 renal fibrosis 9.9
526 villous adenoma 9.9
527 lymphoma 9.9
528 thrombosis 9.9
529 obstructive nephropathy 9.9
530 cloacal exstrophy 9.9
531 myiasis 9.9
532 renal tubular acidosis 9.9
533 constipation 9.9
534 cystic teratoma 9.9
535 epidermolysis bullosa 9.9
536 junctional epidermolysis bullosa 9.9
537 mammary paget's disease 9.9
538 paraphimosis 9.9
539 hemorrhoid 9.9
540 sacrococcygeal teratoma 9.9
541 spinal shock 9.9
542 hypotrichosis 1 9.9 TNF IL6 CXCL8 CD4
543 cholangitis, primary sclerosing 9.9 TNF IL6 CD40LG CD4
544 allergic contact dermatitis 9.9 TNF IL6 CXCL8 CD4
545 bone resorption disease 9.9 TNF IL6 CRP
546 mastitis 9.9 TLR2 IL6 CXCL8
547 retinal vein occlusion 9.9 TNF IL6 CXCL8 CD40LG
548 laryngitis 9.9 TNF IL6 CRP CD40LG
549 dengue hemorrhagic fever 9.9 TNF IL6 CXCL8 CD40LG
550 polyradiculopathy 9.9 TNF IL6 CRP CD40LG
551 erysipelas 9.9 TNF IL6 CRP CD40LG
552 mumps 9.9 TNF IL6 CXCL8 CD40LG
553 hepatic vascular disease 9.9 TNF IL6 CRP CD40LG
554 spondylarthropathy 9.9 TNF TLR4 TLR2
555 vein disease 9.9 TNF IL6 CRP CD40LG
556 purpura 9.9 TNF IL6 CRP CD40LG
557 leukocyte disease 9.9 TNF IL6 CD40LG CD4
558 silicosis 9.9 TNF TLR4 CXCL8
559 takayasu arteritis 9.9 TNF IL6 CRP CD40LG
560 plasmodium falciparum malaria 9.9 TNF IL6 CRP CD40LG
561 alveolar echinococcosis 9.9 TNF TLR4 TLR2
562 adult-onset still's disease 9.9 TNF IL6 CXCL8 CRP
563 apnea, obstructive sleep 9.9 TNF IL6 CXCL8 CRP
564 demyelinating disease 9.9 TNF IL6 CD40LG CD4
565 sudden infant death syndrome 9.9 TNF IL6 HSPD1 CXCL8
566 biliary tract disease 9.9 TNF IL6 CRP CD40LG
567 retinal vascular disease 9.9 TNF IL6 CXCL8 CRP
568 exudative vitreoretinopathy 1 9.9 TNF IL6 CXCL8 CRP
569 paranasal sinus disease 9.9 TNF CXCL8 CRP CD40LG CD4
570 sickle cell anemia 9.9 TNF IL6 CD40LG
571 autosomal genetic disease 9.9 TNF IL6 CXCL8 CD4
572 diabetes insipidus, nephrogenic, autosomal 9.9
573 kaposi sarcoma 9.9
574 klippel-trenaunay-weber syndrome 9.9
575 polykaryocytosis inducer 9.9
576 hemihyperplasia, isolated 9.9
577 immune deficiency disease 9.9
578 ocular motor apraxia 9.9
579 cervical cancer 9.9
580 hemorrhagic cystitis 9.9
581 omphalocele 9.9
582 benign teratoma 9.9
583 rickets 9.9
584 bladder calculus 9.9
585 potter's syndrome 9.9
586 balanoposthitis 9.9
587 bladder leiomyoma 9.9
588 oligospermia 9.9
589 hypothyroidism 9.9
590 cholera 9.9
591 leiomyosarcoma 9.9
592 urogenital tuberculosis 9.9
593 sensory peripheral neuropathy 9.9
594 cystic lymphangioma 9.9
595 papillary adenocarcinoma 9.9
596 embryonal rhabdomyosarcoma 9.9
597 pseudohermaphroditism 9.9
598 carcinosarcoma 9.9
599 lymphocele 9.9
600 mature teratoma 9.9
601 muscular atrophy 9.9
602 diabetes insipidus 9.9
603 pulmonary embolism 9.9
604 alopecia 9.9
605 weber syndrome 9.9
606 hypotonia 9.9
607 posttransplant acute limbic encephalitis 9.9
608 rapidly involuting congenital hemangioma 9.9
609 inflammatory myopathy with abundant macrophages 9.9
610 fetal lower urinary tract obstruction 9.9
611 shigellosis 9.9 TNF TLR4 CXCL8
612 sleep apnea 9.9 TNF IL6 CXCL8 CRP
613 tetanus 9.9 TNF IL6 CRP CD40LG
614 juvenile rheumatoid arthritis 9.9 TNF IL6 CXCL8 CRP
615 blau syndrome 9.9 TNF TLR4 TLR2
616 rheumatic fever 9.9 TNF TLR2 IL6 CD40LG
617 bone remodeling disease 9.9 TNF IL6 CRP
618 polyneuropathy 9.9 TNF IL6 CRP CD40LG
619 periapical periodontitis 9.9 TNF TLR2 IL6 CXCL8
620 adult respiratory distress syndrome 9.9 TNF IL6 CXCL8
621 chronic mucocutaneous candidiasis 9.9 TNF TLR2 IL6 CD4
622 chorioretinitis 9.8 TNF MRAP IL6 CD40LG CD4
623 agammaglobulinemia 9.8 TNF TLR2 IL6 CD40LG
624 infective endocarditis 9.8 TNF TLR2 IL6 CRP
625 cinca syndrome 9.8 TLR4 IL6 CRP
626 coronary stenosis 9.8 TLR4 IL6 CRP
627 aortitis 9.8 TNF MRAP IL6 CRP CD40LG
628 invasive aspergillosis 9.8 TLR4 TLR2 CXCL8 CD4
629 optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy 9.8
630 beckwith-wiedemann syndrome 9.8
631 renal cell carcinoma, nonpapillary 9.8
632 neurofibromatosis, type iv, of riccardi 9.8
633 polydactyly, postaxial, type a1 9.8
634 dowling-degos disease 1 9.8
635 vater/vacterl association 9.8
636 lipoid congenital adrenal hyperplasia 9.8
637 aging 9.8
638 wilms tumor 5 9.8
639 alveolar soft part sarcoma 9.8
640 hypertrophic scars 9.8
641 deficiency anemia 9.8
642 peyronie's disease 9.8
643 small cell carcinoma 9.8
644 paraganglioma 9.8
645 ectopic pregnancy 9.8
646 meningococcal meningitis 9.8
647 esophageal atresia 9.8
648 renal hypertension 9.8
649 malignant hypertension 9.8
650 vaginal cancer 9.8
651 dementia 9.8
652 hyperparathyroidism 9.8
653 azoospermia 9.8
654 ectropion 9.8
655 keratosis 9.8
656 neuroendocrine tumor 9.8
657 rectum adenocarcinoma 9.8
658 vulvar melanoma 9.8
659 hidradenitis suppurativa 9.8
660 hidradenitis 9.8
661 testicular cancer 9.8
662 papillary carcinoma 9.8
663 ischemia 9.8
664 fibrosarcoma 9.8
665 plasmacytoma 9.8
666 spindle cell carcinoma 9.8
667 hyperglycemia 9.8
668 somatoform disorder 9.8
669 severe combined immunodeficiency 9.8
670 neuroblastoma 9.8
671 polyhydramnios 9.8
672 cervix uteri carcinoma in situ 9.8
673 gas gangrene 9.8
674 diabetic neuropathy 9.8
675 hydrocele 9.8
676 cervical intraepithelial neoplasia 9.8
677 chromosomal triplication 9.8
678 congenital extrahepatic portosystemic shunt 9.8
679 distal renal tubular acidosis 9.8
680 eosinophilic cystitis 9.8
681 intravascular papillary endothelial hyperplasia 9.8
682 meningococcemia 9.8
683 soft tissue sarcoma 9.8
684 hypoxia 9.8
685 paresthesia 9.8
686 syncope 9.8
687 multicystic dysplastic kidney 9.8
688 obsolete: atypical teratoid/rhabdoid tumor 9.8
689 penile agenesis 9.8
690 vaginal atresia 9.8
691 lymphedema 9.8
692 rare surgical neurologic disease 9.8
693 suppurative otitis media 9.8 TLR4 TLR2 CRP CD40LG
694 osteoarthritis 9.8 TNF IL6 CXCL8 CRP
695 lichen disease 9.8 TNF IL6 CXCL8 CD40LG CD4
696 lacrimal apparatus disease 9.8 TNF IL6 CXCL8 CD40LG CD4
697 viral encephalitis 9.8 TNF IL6 CXCL8 CD40LG CD4
698 lung abscess 9.8 TNF IL6 CRP CD40LG CD4
699 cysticercosis 9.8 TLR4 IL6 CD40LG CD4
700 central nervous system vasculitis 9.8 TNF IL6 CRP CD40LG CD4
701 hantavirus hemorrhagic fever with renal syndrome 9.8 TNF IL6 CRP CD40LG CD4
702 hypersensitivity reaction type iii disease 9.8 TNF IL6 CRP CD40LG CD4
703 pneumocystosis 9.8 TNF IL6 CRP CD40LG CD4
704 pericardium disease 9.8 TNF IL6 CRP CD40LG CD4
705 lymphoid interstitial pneumonia 9.8 TNF IL6 CRP CD40LG CD4
706 meningoencephalitis 9.8 TNF IL6 CRP CD40LG CD4
707 temporal arteritis 9.8 TNF IL6 CRP CD40LG CD4
708 collagen disease 9.8 TNF IL6 CRP CD40LG CD4
709 blood coagulation disease 9.8 TNF IL6 CRP CD40LG CD4
710 lymphatic system disease 9.8 TNF IL6 CRP CD40LG CD4
711 familial hypercholesterolemia 9.8 TNF IL6 CXCL8 CRP
712 bile duct disease 9.8 TNF IL6 CRP CD40LG CD4
713 optic nerve disease 9.7 TNF IL6 CRP CD40LG CD4
714 blood platelet disease 9.7 TNF IL6 CRP CD40LG CD4
715 viral pneumonia 9.7 TNF IL6 CXCL8 CRP CD4
716 systemic scleroderma 9.7 TNF IL6 CRP CD40LG CD4
717 pleural disease 9.7 TNF IL6 CXCL8 CRP CD4
718 cecal disease 9.7 TNF IL6 CXCL8 CRP CD40LG
719 gingivitis 9.7 TNF TLR2 IL6 DEFB4A CXCL8
720 pericarditis 9.7 TNF IL6 CXCL8 CRP CD40LG
721 severe acute respiratory syndrome 9.7 TNF IL6 CXCL8 CRP CD40LG
722 common variable immunodeficiency 9.7 TNF TLR2 IL6 CD40LG
723 interstitial lung disease 9.7 TNF IL6 CXCL8 CRP CD40LG
724 essential thrombocythemia 9.7 TNF IL6 CXCL8 CRP CD40LG
725 food allergy 9.7 TNF TLR4 TLR2 CXCL8
726 idiopathic neutropenia 9.7 TNF TLR4 IL6 CD40LG
727 rubella 9.7 TNF TLR4 IL6 CD40LG
728 cystic echinococcosis 9.7 TLR4 TLR2 IL6 CD40LG
729 mycoplasma pneumoniae pneumonia 9.7 TNF TLR2 IL6 CRP CD40LG
730 leukemia, acute monocytic 9.7 TNF TLR4 IL6 CXCL8
731 duodenal ulcer 9.7 TNF TLR4 IL6 CXCL8
732 prosthetic joint infection 9.6 TLR4 TLR2 IL6 CRP
733 alcohol dependence 9.6
734 anorectal anomalies 9.6
735 breasts and/or nipples, aplasia or hypoplasia of, 1 9.6
736 burkitt lymphoma 9.6
737 cleft palate, isolated 9.6
738 coloboma of macula 9.6
739 factor viii deficiency 9.6
740 hirschsprung disease 1 9.6
741 lipomatosis, multiple 9.6
742 macroglossia 9.6
743 medulloblastoma 9.6
744 hemifacial microsomia 9.6
745 obsessive-compulsive disorder 9.6
746 teratoma, ovarian 9.6
747 parkinson disease, late-onset 9.6
748 phosphatase, acid, of tissues 9.6
749 pick disease of brain 9.6
750 pneumothorax, primary spontaneous 9.6
751 silver-russell syndrome 9.6
752 sprengel deformity 9.6
753 syringomyelia, noncommunicating isolated 9.6
754 testicular torsion 9.6
755 thrombophilia due to thrombin defect 9.6
756 tracheoesophageal fistula with or without esophageal atresia 9.6
757 suppressor of tumorigenicity 3 9.6
758 vitiligo-associated multiple autoimmune disease susceptibility 6 9.6
759 alkaptonuria 9.6
760 arachnoid cysts, intracranial 9.6
761 autism 9.6
762 congenital heart defects, hamartomas of tongue, and polysyndactyly 9.6
763 fraser syndrome 1 9.6
764 dandy-walker syndrome 9.6
765 epidermolysis bullosa, junctional, non-herlitz type 9.6
766 gastroschisis 9.6
767 holoprosencephaly 1 9.6
768 hydrops fetalis, nonimmune 9.6
769 johanson-blizzard syndrome 9.6
770 nuchal bleb, familial 9.6
771 pyloric atresia 9.6
772 reticulum cell sarcoma 9.6
773 rhabdomyosarcoma, embryonal, 1 9.6
774 androgen insensitivity syndrome 9.6
775 tubulin, beta 9.6
776 hemophilia a 9.6
777 sacral defect with anterior meningocele 9.6
778 helicobacter pylori infection 9.6
779 frontotemporal dementia 9.6
780 adenomyosis 9.6
781 gallbladder disease 1 9.6
782 budd-chiari syndrome 9.6
783 renal dysplasia, cystic 9.6
784 stroke, ischemic 9.6
785 body mass index quantitative trait locus 9 9.6
786 body mass index quantitative trait locus 8 9.6
787 urinary tract infections, recurrent 9.6
788 atrioventricular septal defect 9.6
789 longevity 2 9.6
790 vitiligo-associated multiple autoimmune disease susceptibility 1 9.6
791 patent ductus arteriosus 1 9.6
792 body mass index quantitative trait locus 4 9.6
793 body mass index quantitative trait locus 10 9.6
794 anxiety 9.6
795 caudal duplication anomaly 9.6
796 hypertensive nephropathy 9.6
797 body mass index quantitative trait locus 7 9.6
798 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 9.6
799 testicular microlithiasis 9.6
800 body mass index quantitative trait locus 12 9.6
801 body mass index quantitative trait locus 14 9.6
802 lung cancer susceptibility 3 9.6
803 multiple sclerosis 2 9.6
804 vesicoureteral reflux 5 9.6
805 periodic fever, menstrual cycle-dependent 9.6
806 human herpesvirus 8 9.6
807 retinal dystrophy, iris coloboma, and comedogenic acne syndrome 9.6
808 body mass index quantitative trait locus 18 9.6
809 alacrima, achalasia, and mental retardation syndrome 9.6
810 hyperprolactinemia 9.6
811 neurodegeneration with brain iron accumulation 6 9.6
812 carbonic anhydrase va deficiency, hyperammonemia due to 9.6
813 autoimmune lymphoproliferative syndrome, type v 9.6
814 chorea, childhood-onset, with psychomotor retardation 9.6
815 body mass index quantitative trait locus 19 9.6
816 body mass index quantitative trait locus 20 9.6
817 pulmonary hypertension 9.6
818 paramyloidosis 9.6
819 androgenic alopecia 9.6
820 limb ischemia 9.6
821 fibroma 9.6
822 munchausen by proxy 9.6
823 diffuse alopecia areata 9.6
824 ileocolitis 9.6
825 atrial fibrillation 9.6
826 umbilical hernia 9.6
827 latex allergy 9.6
828 isolated growth hormone deficiency 9.6
829 spina bifida occulta 9.6
830 mucositis 9.6
831 polycystic kidney disease 9.6
832 nodular malignant melanoma 9.6
833 pleomorphic lipoma 9.6
834 sialadenitis 9.6
835 yaws 9.6
836 interstitial nephritis 9.6
837 premature menopause 9.6
838 microcephaly 9.6
839 amnestic disorder 9.6
840 transsexualism 9.6
841 hemiplegia 9.6
842 acute salpingitis 9.6
843 prostatic cyst 9.6
844 anhidrosis 9.6
845 spondyloarthropathy 9.6
846 megacolon 9.6
847 subdural empyema 9.6
848 xanthogranulomatous pyelonephritis 9.6
849 hemopericardium 9.6
850 cauda equina syndrome 9.6
851 polycystic ovary syndrome 9.6
852 gestational diabetes 9.6
853 bladder sarcoma 9.6
854 ureteral benign neoplasm 9.6
855 inflammatory spondylopathy 9.6
856 varicocele 9.6
857 vulva cancer 9.6
858 secondary hyperparathyroidism 9.6
859 von willebrand's disease 9.6
860 acute kidney tubular necrosis 9.6
861 pyloric stenosis 9.6
862 locked-in syndrome 9.6
863 hereditary hemorrhagic telangiectasia 9.6
864 telangiectasis 9.6
865 guillain-barre syndrome 9.6
866 choreatic disease 9.6
867 hypochondriasis 9.6
868 renal osteodystrophy 9.6
869 klebsiella pneumonia 9.6
870 diphtheritic cystitis 9.6
871 premature ejaculation 9.6
872 urinary schistosomiasis 9.6
873 vulvar dystrophy 9.6
874 estrogen excess 9.6
875 dracunculiasis 9.6
876 chronic cervicitis 9.6
877 alcohol use disorder 9.6
878 rheumatic disease 9.6
879 chronic interstitial cystitis 9.6
880 heart septal defect 9.6
881 factitious disorder 9.6
882 neuroendocrine carcinoma 9.6
883 status epilepticus 9.6
884 malignant skin fibrous histiocytoma 9.6
885 hypogonadism 9.6
886 giant cell tumor 9.6
887 ectodermal dysplasia 9.6
888 dental caries 9.6
889 carbuncle 9.6
890 ascending colon cancer 9.6
891 myeloproliferative neoplasm 9.6
892 thrombocytosis 9.6
893 motor neuron disease 9.6
894 craniosynostosis 9.6
895 iron metabolism disease 9.6
896 glandular cystitis 9.6
897 angiodysplasia 9.6
898 cystadenoma 9.6
899 myoma 9.6
900 glomerulonephritis 9.6
901 cystic kidney disease 9.6
902 iga glomerulonephritis 9.6
903 germ cell cancer 9.6
904 substance abuse 9.6
905 glioblastoma multiforme 9.6
906 inverted papilloma 9.6
907 neurilemmoma 9.6
908 prostate rhabdomyosarcoma 9.6
909 syringomyelia 9.6
910 liposarcoma 9.6
911 inappropriate adh syndrome 9.6
912 signet ring cell adenocarcinoma 9.6
913 lung benign neoplasm 9.6
914 bladder adenocarcinoma 9.6
915 ovary adenocarcinoma 9.6
916 extramedullary plasmacytoma 9.6
917 verrucous carcinoma 9.6
918 hermaphroditism 9.6
919 granuloma annulare 9.6
920 arthropathy 9.6
921 hidrocystoma 9.6
922 vulvitis 9.6
923 papillary transitional carcinoma 9.6
924 tick infestation 9.6
925 pseudohypoaldosteronism 9.6
926 hypokalemia 9.6
927 holoprosencephaly 9.6
928 epidermolysis bullosa simplex 9.6
929 calciphylaxis 9.6
930 adenocarcinoma in situ 9.6
931 epidermolysis bullosa dystrophica 9.6
932 elephantiasis 9.6
933 cellular leiomyoma 9.6
934 hydrarthrosis 9.6
935 vagina leiomyosarcoma 9.6
936 pituitary gland disease 9.6
937 penis squamous cell carcinoma 9.6
938 ovarian germ cell teratoma 9.6
939 malignant mesenchymoma 9.6
940 oral submucous fibrosis 9.6
941 congestive heart failure 9.6
942 spinal stenosis 9.6
943 cloacogenic carcinoma 9.6
944 anal canal squamous cell carcinoma 9.6
945 hypogonadotropism 9.6
946 situs inversus 9.6
947 gastrointestinal system disease 9.6
948 delusional disorder 9.6
949 nephrogenic adenoma of the urethra 9.6
950 intestinal obstruction 9.6
951 reticulosarcoma 9.6
952 subacute delirium 9.6
953 skin melanoma 9.6
954 achalasia 9.6
955 neurofibroma 9.6
956 renal tuberculosis 9.6
957 hypereosinophilic syndrome 9.6
958 hemophilia 9.6
959 keloid disorder 9.6
960 actg2-related disorders 9.6
961 bap1 tumor predisposition syndrome 9.6
962 craniofacial microsomia 9.6
963 47, xxy 9.6
964 abdominal cystic lymphangioma 9.6
965 allergic encephalomyelitis 9.6
966 bowen's disease 9.6
967 candida glabrata 9.6
968 complete androgen insensitivity syndrome 9.6
969 cytokine deficiency 9.6
970 cytomegalic inclusion disease 9.6
971 dextrocardia with situs inversus 9.6
972 diaphragmatic flutter 9.6
973 encephalocele 9.6
974 enterovesical fistula 9.6
975 erythroplakia 9.6
976 germ cells tumors 9.6
977 growth hormone deficiency 9.6
978 hansen's disease 9.6
979 hemangioendothelioma 9.6
980 lymphosarcoma 9.6
981 non-involuting congenital hemangioma 9.6
982 nonseminomatous germ cell tumor 9.6
983 oto-palatal-digital syndrome 9.6
984 ovarian epithelial cancer 9.6
985 parainfluenza virus type 3 9.6
986 penile cancer, adult 9.6
987 pustular psoriasis 9.6
988 urachal adenocarcinoma 9.6
989 urachal cancer 9.6
990 vagina, absence of 9.6
991 vulvar vestibulitis syndrome 9.6
992 abdominal wall defect 9.6
993 angiomatosis 9.6
994 anoxia 9.6
995 brain injury 9.6
996 tremor 9.6
997 rectal duplication 9.6
998 angioosteohypertrophic syndrome 9.6
999 bicornuate uterus 9.6
1000 septate vagina 9.6
1001 adrenogenital syndrome 9.6
1002 occipital encephalocele 9.6
1003 solitary rectal ulcer syndrome 9.6
1004 fixed drug eruption 9.6
1005 urachal diverticulum 9.6
1006 erythema multiforme major 9.6
1007 transient pseudohypoaldosteronism 9.6
1008 x-linked intellectual disability-macrocephaly-macroorchidism syndrome 9.6
1009 isolated epispadias 9.6
1010 myocarditis 9.6 TNF TLR4 IL6 CD40LG
1011 chronic fatigue syndrome 9.6 TNF TLR4 IL6 CXCL8
1012 rosacea 9.6 TNF TLR2 IL6 CXCL8 CRP
1013 portal hypertension 9.6 TNF TLR4 CXCL8 CD40LG CD4
1014 monocytic leukemia 9.6 TNF TLR4 IL6 CXCL8
1015 intracranial berry aneurysm 9.6 TNF TLR4 IL6 CRP
1016 bronchiectasis 9.6 TNF TLR2 IL6 CXCL8 CRP
1017 scleral disease 9.6 TNF MRAP IL6 CRP CD40LG CD4
1018 panuveitis 9.6 TNF MRAP IL6 CRP CD40LG CD4
1019 pertussis 9.6 TNF TLR4 IL6 CXCL8
1020 kawasaki disease 9.6 TNF IL6 HSPD1 CRP CD40LG CD4
1021 lymphadenitis 9.6 TNF TLR4 CXCL8 CRP CD4
1022 overnutrition 9.6 TNF TLR4 IL6 CRP
1023 ileitis 9.6 TNF TLR4 TLR2 IL6
1024 melioidosis 9.6 TNF TLR4 TLR2 IL6
1025 exanthem 9.6 TNF IL6 CXCL8 CRP CD40LG CD4
1026 scrub typhus 9.5 TNF TLR4 TLR2 CRP CD40LG
1027 coronary artery anomaly 9.5 TNF IL6 CXCL8 CRP CD40LG CD4
1028 spondyloarthropathy 1 9.5 TNF TLR4 MRAP HSPD1 CRP CD40LG
1029 noonan syndrome 1 9.5 TNF TLR4 CXCL8 CD40LG CD4
1030 lyme disease 9.5 TNF TLR2 IL6 HSPD1 CRP CD40LG
1031 autoimmune disease of gastrointestinal tract 9.5 TNF TLR4 IL6 CD40LG CD4
1032 pleurisy 9.5 TNF TLR4 TLR2 CXCL8 CRP
1033 visceral leishmaniasis 9.5 TNF TLR4 TLR2 CXCL8 CRP
1034 hellp syndrome 9.5 TLR4 IL6 CXCL8 CRP CD40LG
1035 psoriasis 9.5 TNF TLR2 IL6 DEFB4A CXCL8 CD4
1036 epidemic typhus 9.5 TLR4 TLR2 HSPD1 CRP CD40LG CD4
1037 inflammatory bowel disease 1 9.5 TNF TLR4 TLR2 IL6 DEFB4A
1038 sclerosing cholangitis 9.5 TNF TLR4 IL6 CXCL8 CD40LG
1039 relapsing-remitting multiple sclerosis 9.5 TNF TLR4 IL6 CXCL8 CD40LG
1040 glucose metabolism disease 9.5 TNF TLR4 IL6 CRP CD4
1041 acquired metabolic disease 9.5 TNF TLR4 IL6 CRP CD4
1042 leptospirosis 9.5 TNF TLR2 IL6 CXCL8 CRP CD40LG
1043 appendicitis 9.4 TNF TLR4 IL6 CXCL8 CRP
1044 obstructive jaundice 9.4 TNF TLR4 IL6 CXCL8 CRP
1045 bronchiolitis obliterans 9.4 TNF TLR4 IL6 CXCL8 CRP
1046 gingival overgrowth 9.4 TNF IL6 CXCL8
1047 acute pancreatitis 9.4 TNF TLR4 IL6 CXCL8 CRP
1048 pneumonic tularemia 9.4 TNF TLR4 TLR2 IL6 CD4
1049 fatty liver disease 9.4 TNF TLR4 IL6 CXCL8 CRP
1050 listeriosis 9.4 TNF TLR4 TLR2 IL6 CD4
1051 plague 9.4 TNF TLR4 TLR2 IL6 CD4
1052 paracoccidioidomycosis 9.4 TNF TLR4 TLR2 IL6 CD40LG
1053 q fever 9.4 TNF TLR4 TLR2 IL6 CD40LG
1054 uveal disease 9.4 TNF MRAP IL6 CXCL8 CRP CD40LG
1055 gastritis 9.4 TNF TLR4 IL6 DEFB4A DEFA5 CXCL8
1056 non-alcoholic fatty liver disease 9.4 TNF TLR4 IL6 CXCL8 CRP
1057 toxoplasmosis 9.4 TNF TLR4 TLR2 IL6 CD40LG
1058 dental pulp disease 9.4 TNF TLR4 TLR2 IL6 CXCL8
1059 endometrial disease 9.4 TNF TLR4 TLR2 IL6 CXCL8
1060 aphthous stomatitis 9.4 TNF TLR4 TLR2 IL6 CXCL8
1061 tonsillitis 9.4 TNF TLR4 TLR2 IL6 CXCL8
1062 cutaneous leishmaniasis 9.4 TNF TLR4 TLR2 IL6 CXCL8
1063 alcoholic liver cirrhosis 9.4 TNF TLR4 TLR2 IL6 CXCL8
1064 gout 9.4 TNF TLR4 TLR2 IL6 CXCL8
1065 aspergillosis 9.4 TNF TLR4 TLR2 IL6 CXCL8
1066 trypanosomiasis 9.4 TNF TLR4 TLR2 IL6 CXCL8
1067 filariasis 9.4 TNF TLR4 TLR2 IL6 CRP
1068 familial mediterranean fever 9.4 TNF TLR4 TLR2 IL6 CRP
1069 pulmonary tuberculosis 9.4 TNF TLR4 TLR2 IL6 CRP
1070 primary biliary cirrhosis 9.4 TNF TLR4 IL6 HSPD1 CD40LG CD4
1071 hepatitis b 9.4 TNF TLR4 TLR2 IL6 CXCL8
1072 atherosclerosis susceptibility 9.3 TNF TLR4 IL6 HSPD1 CXCL8 CRP
1073 penile disease 9.3 TNF TLR4 TLR2 MRAP IL6 CD4
1074 aggressive periodontitis 9.3 TNF TLR4 TLR2 IL6 DEFB4A CXCL8
1075 brucellosis 9.3 TNF TLR4 IL6 CXCL8 CRP CD40LG
1076 cholangitis 9.3 TNF TLR4 IL6 CXCL8 CRP CD40LG
1077 herpangina 9.2 TNF TLR4 TLR2 IL6 CD40LG CD4
1078 parasitic helminthiasis infectious disease 9.2 TNF TLR4 TLR2 IL6 CD40LG CD4
1079 pre-eclampsia 9.2 TNF TLR4 IL6 CXCL8 CRP CD40LG
1080 nasal cavity disease 9.2 TNF TLR4 TLR2 IL6 CXCL8 CD4
1081 common cold 9.2 TNF TLR4 TLR2 IL6 CXCL8 CD4
1082 respiratory allergy 9.2 TNF TLR4 TLR2 IL6 CXCL8 CD4
1083 keratitis, hereditary 9.2 TNF TLR4 TLR2 IL6 CXCL8 CD4
1084 corneal disease 9.2 TNF TLR4 TLR2 IL6 CXCL8 CD4
1085 viral hepatitis 9.2 TNF TLR4 TLR2 IL6 CRP CD40LG
1086 psoriatic arthritis 9.2 TNF TLR4 TLR2 IL6 CRP CD40LG
1087 perinatal necrotizing enterocolitis 9.2 TNF TLR4 TLR2 IL6 CXCL8 CRP
1088 bacterial sepsis 9.2 TNF TLR4 TLR2 IL6 CXCL8 CRP
1089 preterm premature rupture of the membranes 9.2 TNF TLR4 TLR2 IL6 CXCL8 CRP
1090 bacterial meningitis 9.2 TNF TLR4 TLR2 IL6 CXCL8 CRP
1091 proteasome-associated autoinflammatory syndrome 1 9.2 TNF TLR4 TLR2 IL6 CXCL8 CRP
1092 alcoholic hepatitis 9.2 TNF TLR4 TLR2 IL6 CXCL8 CRP
1093 leishmaniasis 9.2 TNF TLR4 TLR2 IL6 CXCL8 CRP
1094 endocardium disease 9.1 TNF TLR2 IL6 HSPD1 CXCL8 CRP
1095 macular degeneration, age-related, 1 9.1 TNF TLR4 TLR2 IL6 CXCL8 CRP
1096 osteoporosis 9.1 TNF TLR4 IL6 CXCL8 CRP CD40LG
1097 tularemia 9.1 TNF TLR4 TLR2 IL6 HSPD1 CD40LG
1098 testicular disease 9.1 TNF TLR4 TLR2 IL6 HSPD1 CD40LG
1099 bronchopneumonia 9.1 TNF TLR4 IL6 CXCL8 CRP CD40LG
1100 legionellosis 9.1 TNF TLR4 TLR2 IL6 HSPD1 CXCL8
1101 sebaceous gland disease 9.0 TNF TLR4 TLR2 IL6 DEFB4A CXCL8
1102 dilated cardiomyopathy 9.0 TNF TLR4 IL6 HSPD1 CXCL8 CRP
1103 autoimmune disease of central nervous system 9.0 TNF TLR4 TLR2 IL6 CXCL8 CD40LG
1104 viral infectious disease 9.0 TNF TLR4 TLR2 IL6 CXCL8 CD40LG
1105 splenic disease 9.0 TNF TLR4 TLR2 IL6 CRP CD40LG
1106 extrinsic cardiomyopathy 9.0 TNF TLR4 TLR2 IL6 CRP CD40LG
1107 salmonellosis 9.0 TNF TLR4 TLR2 IL6 GPR182 DEFB4A
1108 epididymis disease 9.0 TLR4 NAT9 MRAP KLK3 IL6 CRP
1109 bronchiolitis 9.0 TNF TLR4 TLR2 IL6 CXCL8 CRP
1110 otitis media 9.0 TNF TLR4 TLR2 IL6 CXCL8 CRP
1111 bronchitis 9.0 TNF TLR4 TLR2 IL6 CXCL8 CRP
1112 pulmonary disease, chronic obstructive 9.0 TNF TLR4 TLR2 IL6 CXCL8 CRP
1113 pulmonary fibrosis, idiopathic 9.0 TNF TLR4 TLR2 IL6 CXCL8 CRP
1114 lung disease 9.0 TNF TLR4 TLR2 IL6 CXCL8 CRP
1115 cystic fibrosis 8.9 VDAC1 TNF TLR4 IL6 DEFB4A CXCL8
1116 typhoid fever 8.9 VDAC1 TNF TLR4 IL6 GPR182 CRP
1117 muscular disease 8.9 TNF TLR4 MRAP IL6 CXCL8 CRP
1118 periodontitis 8.9 TNF TLR4 TLR2 IL6 HSPD1 DEFB4A
1119 myocardial infarction 8.9 TNF TLR4 TLR2 IL6 CXCL8 CRP
1120 dermatitis, atopic 8.9 TNF TLR4 TLR2 IL6 DEFB4A CXCL8
1121 primary systemic mycosis 8.9 TNF TLR4 TLR2 IL6 HSPD1 CRP
1122 coccidiosis 8.9 TNF TLR4 TLR2 MRAP IL6 CRP
1123 gingival disease 8.9 TNF TLR4 TLR2 IL6 DEFB4A CXCL8
1124 vaginal disease 8.9 TNF TLR4 TLR2 IL6 DEFB4A CXCL8
1125 diabetes mellitus, insulin-dependent 8.9 TNF TLR4 TLR2 IL6 HSPD1 CRP
1126 blood group, globoside system 8.9 TNF TLR4 TLR2 MRAP IL6 CXCL8
1127 diabetes mellitus, noninsulin-dependent 8.8 TNF TLR4 TLR2 IL6 CXCL8 CRP
1128 middle ear disease 8.8 TNF TLR4 TLR2 IL6 CXCL8 CRP
1129 nose disease 8.8 TNF TLR4 TLR2 IL6 CXCL8 CRP
1130 opportunistic mycosis 8.8 TNF TLR4 TLR2 IL6 CXCL8 CRP
1131 streptococcus pneumonia 8.8 TNF TLR4 TLR2 IL6 CXCL8 CRP
1132 retinitis pigmentosa 8.8 TNF TLR4 NAT9 MRAP IL6 CXCL8
1133 parasitic protozoa infectious disease 8.8 TNF TLR4 TLR2 IL6 CXCL8 CRP
1134 autoimmune disease of musculoskeletal system 8.8 TNF TLR4 TLR2 IL6 CXCL8 CRP
1135 bronchial disease 8.8 TNF TLR4 TLR2 IL6 CXCL8 CRP
1136 upper respiratory tract disease 8.8 TNF TLR4 TLR2 IL6 CXCL8 CRP
1137 immune system disease 8.8 TNF TLR4 TLR2 IL6 CXCL8 CRP
1138 celiac disease 1 8.8 TNF TLR4 TLR2 IL6 CXCL8 CRP
1139 hypertension, essential 8.7 TNF TLR4 TLR2 IL6 CXCL8 CRP
1140 asthma 8.7 TNF TLR4 TLR2 KLK3 IL6 CXCL8
1141 pneumonia 8.7 TNF TLR4 TLR2 IL6 HSPD1 DEFB4A
1142 bacterial pneumonia 8.7 TNF TLR4 TLR2 IL6 DEFB4A CXCL8
1143 chlamydia pneumonia 8.7 TNF TLR4 TLR2 IL6 HSPD1 CXCL8
1144 conjunctival disease 8.7 TNF TLR4 TLR2 MRAP IL6 CXCL8
1145 hypersensitivity reaction type iv disease 8.7 TNF TLR4 TLR2 MRAP IL6 CXCL8
1146 rheumatoid arthritis 8.6 TNF TLR4 TLR2 IL6 HSPD1 CXCL8
1147 malaria 8.6 TNF TLR4 TLR2 IL6 HSPD1 CXCL8
1148 systemic lupus erythematosus 8.6 TNF TLR4 TLR2 IL6 HSPD1 CXCL8
1149 inflammatory bowel disease 8.6 TNF TLR4 TLR2 IL6 HSPD1 DEFB4A
1150 eye disease 8.5 TNF TLR4 TLR2 MRAP IL6 DEFB4A
1151 behcet syndrome 8.5 TNF TLR4 TLR2 MRAP IL6 HSPD1
1152 primary bacterial infectious disease 8.5 TNF TLR4 TLR2 IL6 HSPD1 GPR182
1153 commensal bacterial infectious disease 8.3 TNF TLR4 TLR2 NAT9 IL6 HSPD1
1154 anus disease 8.1 VDAC1 TNF TLR4 TLR2 MTRR MT-TG
1155 connective tissue disease 8.1 VDAC1 TNF TLR4 TLR2 MRAP IL6
1156 fallopian tube disease 7.8 VDAC1 TNF TLR4 TLR2 NAT9 MTRR
1157 rectal disease 7.7 VDAC1 TNF TLR4 TLR2 MTRR MT-TG

Comorbidity relations with Urethritis via Phenotypic Disease Network (PDN): (showing 7, show less)


Acute Cystitis Bladder Neck Obstruction
Cystitis Prostate Cancer
Prostatic Hypertrophy Trigonitis
Urethral Stricture

Graphical network of the top 20 diseases related to Urethritis:



Diseases related to Urethritis

Symptoms & Phenotypes for Urethritis

Drugs & Therapeutics for Urethritis

Drugs for Urethritis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 19, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
2
Lymecycline Approved, Investigational Phase 4 992-21-2 5280963
3
Tetracycline Approved, Vet_approved Phase 4 60-54-8 5353990
4 Antiparasitic Agents Phase 4
5 Antiprotozoal Agents Phase 4
6 Antimalarials Phase 4
7 Antibiotics, Antitubercular Phase 4
8
Aztreonam Approved Phase 2, Phase 3 78110-38-0 5362041 5742832
9 Anti-Infective Agents Phase 2, Phase 3
10 Anti-Bacterial Agents Phase 2, Phase 3
11
Tinidazole Approved, Investigational Phase 2 19387-91-8 5479
12 Alkylating Agents Phase 2
13 Renal Agents Phase 2
14 Anti-Infective Agents, Urinary Phase 2
15 Amdinocillin Pivoxil Phase 2
16
Azithromycin Approved 83905-01-5 55185 447043
17
Cefixime Approved, Investigational 79350-37-1 54362 5362065
18 Anesthetics
19 Central Nervous System Depressants

Interventional clinical trials:

(showing 16, show less)
# Name Status NCT ID Phase Drugs
1 Study of Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Antibiotic Treatment Unknown status NCT01661985 Phase 4 Azithromycin;Doxycycline;lymecycline
2 Mycoplasma Genitalium Antibiotic Susceptibility and Treatment: A Randomized Double-blind Trial of the Efficacy of Azithromycin and Doxycycline for Clinical and Microbiological Cure of M. Genitalium in Men With Nongonococcal Urethritis Completed NCT00358462 Phase 3 Azithromycin;Doxycycline
3 Aztreonam for Pharyngeal Gonorrhea: A Demonstration Study Completed NCT03867734 Phase 2, Phase 3 Aztreonam
4 Phase II Randomized, Placebo-Controlled Double-Blind 4-Arm Trial for the Treatment of Non-Gonococcal Urethritis (NGU): Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole) Completed NCT00322465 Phase 2 Tinidazole;Doxycycline;Azithromycin
5 Prospective Study for Cost-Effectiveness Strategies to Improve Partner Notification: Female Trichomonas and Male Urethritis Studies Completed NCT00207467 Phase 2
6 Mecillinam for Treatment of Genital Chlamydia Infection in Asymptomatic Men Terminated NCT02083276 Phase 2 Pivmecillinamhydrochlorid
7 Study of the Prevalence of a Chronic Inflammatory Condition of the Male Genital Tract at a Distance and Urethritis Following. Completed NCT01732172
8 UROGEN WEL-DONE: Can the Novel Rapid Diagnostic UROGEN WELL D-ONE Detect Common Causes of Urinary Tract Infections and Urethritis? Completed NCT04182230
9 Antimicrobial Susceptibility Patterns of Neisseria Gonorrhea Isolates in an Era of Quinolone Resistance Completed NCT00692822
10 Expedited Partner Therapy as STI Control Among MSM in Peru Completed NCT01720654
11 Does Thoracic Epidural Analgesia Influence Urinary Micturition by Patients Undergoing Thoracic Surgery? An Observational, Prospective Study Completed NCT00976313
12 Effects of Thoracic Epidural Anesthesia on Lower Urinary Tract Function Completed NCT00790231
13 Comparison of Current Standard of Care Versus the Australian Guidelines for Management of Mycoplasma Genitalium Infections Among Men Being Treated for Non-gonococcal Urethritis Recruiting NCT03910907 Comparison of two standard of care regimens
14 Clinical Description of Spondylarthritis and Validation of Assessment of SpondyloArthritis International Society (ASAS) Criteria in West Indian Patients Seen in the Routine Consultation of Rheumatology. Recruiting NCT03564743
15 HD5 Levels in Catheter Versus Bag Urine Specimens in Young Children for the Diagnosis of UTI Recruiting NCT03163394
16 Do Women Receiving Low Dose Combined Spinal Epidural for Labor Analgesia Exhibit Less Bacteriuria Using a Urinary Retention Protocol Versus Routine Urinary Catheter Placement? Terminated NCT01597791

Search NIH Clinical Center for Urethritis

Inferred drug relations via UMLS 71 / NDF-RT 50 :


ERYTHROMYCIN PWDR

Cochrane evidence based reviews: urethritis

Genetic Tests for Urethritis

Anatomical Context for Urethritis

MalaCards organs/tissues related to Urethritis:

40
Prostate, Testes, Kidney, Skin, Heart, Lung, Bone

Publications for Urethritis

Articles related to Urethritis:

(showing 4511, show less)
# Title Authors PMID Year
1
Antibodies to Chlamydia trachomatis heat-shock protein 60 kDa and detection of Mycoplasma genitalium and ureaplasma urealyticum are associated independently with chronic nongonococcal urethritis. 54 61
12567170 2003
2
Isotretinoin induced urethritis: A case report & review of the literature. 61
31908966 2020
3
Antimicrobial resistance in sexually transmitted infections. 61
31840758 2020
4
A Rare Cause of a Scrotal Abscess due to the Symbiotic Infection of Gardnerella vaginalis and Prevotella bivia in an Adult Male. 61
32024139 2020
5
Comparative results of the implementation in daily practice of an evaluation checklist for patients with axial spondyloarthritis and psoriatic arthritis. 61
32037148 2020
6
Repeat Episodes of Symptomatic Urethritis Due to a Uropathogenic Meningococcal Clade. 61
31651709 2020
7
First isolation of human adenovirus type 85 by molecular analysis of adenoviruses in cases of urethritis. 61
31971505 2020
8
Evaluation of the ResistancePlus® MG FleXible cartridge for near point-of-care testing of Mycoplasma genitalium and associated macrolide resistance mutations. 61
31896664 2020
9
[Evaluation of the composition of the microbiota of the urethra in men with sexually transmitted infections]. 61
32003164 2020
10
Mycoplasma genitalium: A Review. 61
31329090 2020
11
A profile of the cobas® TV/ MG test for the detection of Trichomonas vaginalis and Mycoplasma genitalium. 61
31917618 2020
12
Recreational drugs and STI diagnoses among patients attending an STI/HIV reference clinic in Rome, Italy. 61
31101722 2019
13
Lack of Association Between the S83I ParC Mutation in Mycoplasma genitalium and Treatment Outcomes Among Men Who Have Sex With Men with Nongonococcal Urethritis. 61
31259853 2019
14
Emergence of multidrug resistance among Haemophilus parainfluenzae from respiratory and urogenital samples in Barcelona, Spain. 61
31828685 2019
15
MgpB Types among Mycoplasma genitalium Strains from Men Who Have Sex with Men in Berlin, Germany, 2016-2018. 61
31861901 2019
16
Men at risk of gonococcal urethritis: a case-control study in a Darwin sexual health clinic. 61
31752720 2019
17
Impact of mass drug administration of azithromycin for trachoma elimination on prevalence and azithromycin resistance of genital Mycoplasma genitalium infection. 61
30981999 2019
18
Gonorrhoea. 61
31754194 2019
19
National Institute of Allergy and Infectious Diseases workshop report: "Chlamydia vaccines: The way forward". 61
29097007 2019
20
High rates of treatment failure for Mycoplasma genitalium among men and women attending a sexual health clinic. 61
31722934 2019
21
The clinical efficacy of garenoxacin for male non-gonococcal urethritis. 61
31757739 2019
22
Resolution of Symptoms and Resumption of Sex After Diagnosis of Nongonococcal Urethritis Among Men Who Have Sex With Men. 61
31356530 2019
23
A case report of necrotizing fasciitis with growth of Actinomyces europaeus and Actinotignum schaalii. 61
31636892 2019
24
Behaviors and Energy Source of Mycoplasma gallisepticum Gliding. 61
31308069 2019
25
Infections caused by Chlamydia trachomatis (including lymphogranuloma venereum) and Mycoplasma genitalium. 61
30878312 2019
26
Invasive Ureaplasma Infection in Patients Receiving Rituximab and Other Humoral Immunodeficiencies-A Case Report and Review of the Literature. 61
31660361 2019
27
[Prevalence and role of IgG anti-Chlamydia trachomatis in a population of infertile men in Morocco]. 61
31473105 2019
28
Hematogenous dissemination of Chlamydia muridarum from the urethra in macrophages causes testicular infection and sperm DNA damage†. 61
31373361 2019
29
Aetiology and prevalence of mixed-infections and mono-infections in non-gonococcal urethritis in men: a case-control study. 61
31515293 2019
30
[Non-gonococcal urethritis in men]. 61
31535818 2019
31
Polymerase chain reaction assay in acute urethritis. 61
31273814 2019
32
The Role of Ureaplasma spp. in the Development of Nongonococcal Urethritis and Infertility among Men. 61
31270127 2019
33
Sexually Transmitted Infections: Prevention, Diagnosis, and Treatment in Primary Care. 61
31505011 2019
34
Roles of Ureaplasma Species in Idiopathic Chronic Prostatitis: A Case-Control Study. 61
30799562 2019
35
Urogenital chlamydia trachomatis treatment failure with azithromycin: A meta-analysis. 61
31646255 2019
36
Mycoplasma genitalium, a stealth female reproductive tract. 61
31522281 2019
37
Hechtia glomerata Zucc: Phytochemistry and Activity of Its Extracts and Major Constituents Against Resistant Bacteria. 61
31546651 2019
38
Evolving patterns of reactive arthritis. 61
30919146 2019
39
Mycoplasma genitalium Nongonococcal Urethritis Is Likely to Increase in Men Who Have Sex With Men Who Practice Unsafe Sex: What Should We Do? 61
31295219 2019
40
Men Who Have Sex With Men With Mycoplasma genitalium-Positive Nongonococcal Urethritis Are More Likely to Have Macrolide-Resistant Strains Than Men With Only Female Partners: A Prospective Study. 61
31295218 2019
41
Gonococcal infection: An unresolved problem. 61
30732970 2019
42
Mycoplasma genitalium macrolide resistance update: Rate among a 2016-2017 cohort of patients in Barcelona, Spain. 61
31445815 2019
43
Community-based strategies to identify the unmet need for care of individuals with sexually transmitted infection-associated symptoms in rural South Africa. 61
31141301 2019
44
Onychocryptosis and asymptomatic external urethritis as complications of oral isotretinoin therapy. 61
31413063 2019
45
Mycoplasma genitalium Infections in Women Attending a Sexually Transmitted Disease Clinic in New Orleans. 61
30351348 2019
46
Migratory Polyarthritis in the Setting of Chlamydial Infection. 61
31565624 2019
47
Management of gonorrhoea in a hospital network: are we following best practice? 61
31292064 2019
48
An overview of reactive arthritis. 61
31169570 2019
49
Detection of Rectal Chlamydia trachomatis in Heterosexual Men Who Report Cunnilingus. 61
31194715 2019
50
Classification of non-gonococcal urethritis: a review. 61
30953260 2019
51
Mycoplasma genitalium nongonococcal urethritis is likely to increase in men who have sex with men who practice unsafe sex: What should we do? 61
31188279 2019
52
Long Duration of Asymptomatic Mycoplasma genitalium Infection After Syndromic Treatment for Nongonococcal Urethritis. 61
30281079 2019
53
Selected Immunological Mediators and Cervical Microbial Signatures in Women with Chlamydia trachomatis Infection. 61
31164450 2019
54
Estimate of male urethritis incidences in France between 2007 and 2017 with a specific focus on Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis infections. 61
31248368 2019
55
Cross-sectional study of urethral exposures at last sexual episode associated with non-gonococcal urethritis among STD clinic patients. 61
30181326 2019
56
Delay in Seeking Health Care Services After Onset of Urethritis Symptoms in Men. 61
30985634 2019
57
Neonatal Conjunctivitis Caused by Neisseria meningitidis US Urethritis Clade, New York, USA, August 2017. 61
31002061 2019
58
A 'pathogenic needle' in a 'commensal haystack': Genetic virulence signatures of Corynebacterium glucuronolyticum that may drive its infectious propensity for the male urogenital system. 61
31010496 2019
59
Homophobia and heteronormativity as dimensions of stigma that influence sexual risk behaviors among men who have sex with men (MSM) and women (MSMW) in Lima, Peru: a mixed-methods analysis. 61
31113398 2019
60
Sexual behavior and sexually transmitted infection in the elderly population of South Korea. 61
31098428 2019
61
Disseminated adenovirus infection in a patient with relapsed refractory multiple myeloma undergoing autologous stem cell transplantation and pomalidomide/dexamethasone as salvage regimens. 61
30642772 2019
62
Chlamydia trachomatis and Chlamydia pneumoniae Interaction with the Host: Latest Advances and Future Prospective. 61
31100923 2019
63
Ureaplasma urealyticum pyelonephritis presenting with progressive dysuria, renal failure, and neurologic symptoms in an immunocompromised patient. 61
30472777 2019
64
Symptoms, Sites, and Significance of Mycoplasma genitalium in Men Who Have Sex with Men. 61
30882306 2019
65
Mycoplasma genitalium in symptomatic male urethritis: macrolide use is associated with increased resistance. 61
30972419 2019
66
Is it time for the US and Canada to reconsider macrolides as the first line empiric treatment for males with symptomatic urethritis? 61
30972414 2019
67
Men who have sex with men with Mycoplasma genitalium-positive nongonococcal urethritis are more likely to have macrolide resistant strains than men with only female partners: a prospective study. 61
31008841 2019
68
Failure of syndromic management due to drug-resistant Mycoplasma genitalium infection in South Africa: a case report. 61
30714876 2019
69
Two cases of multidrug-resistant genitourinary Mycoplasma genitalium infection successfully eradicated with minocycline. 61
30999836 2019
70
[Medical prevention and treatment of radiation-induced urological and nephrological complications]. 61
30898418 2019
71
[Management of urethral stones in dogs using pneumatic and laser lithotripsy]. 61
31013525 2019
72
Rationale for a Neisseria gonorrhoeae Susceptible Only Interpretive Breakpoint for Azithromycin. 61
30963175 2019
73
Evaluation of Susceptibilities to Carbapenems and Faropenem Against Cephalosporin-Resistant Neisseria gonorrhoeae Clinical Isolates with penA Mosaic Alleles. 61
30676251 2019
74
Primary Syphilis in the Male Urethra: A Case Report. 61
30202933 2019
75
Outcomes of Resistance-guided Sequential Treatment of Mycoplasma genitalium Infections: A Prospective Evaluation. 61
29873691 2019
76
A microbial game of whack-a-mole: clinical case series of the urethral uncloaking phenomenon caused by Corynebacterium glucuronolyticum in men treated for Chlamydia trachomatis urethritis. 61
30168068 2019
77
Naphthalene induced acute kidney injury in an African patient in Ghana: a case report. 61
31312313 2019
78
Haemophilus Species Isolated in Urethral Exudates as a Possible Causative Agent in Acute Urethritis: A Study of 38 Cases. 61
30390917 2019
79
[Management of acquired urethral stricture: our experience in the Division of General Surgery in Sikasso]. 61
31692786 2019
80
Gonococcal conjunctivitis after incomplete treatment of gonococcal urethritis. 61
31213856 2019
81
Infectious human adenoviruses are shed in urine even after disappearance of urethral symptoms. 61
30840641 2019
82
Heteroresistance to the model antimicrobial peptide polymyxin B in the emerging Neisseria meningitidis lineage 11.2 urethritis clade: mutations in the pilMNOPQ operon. 61
30338585 2019
83
Detection of ureaplasmas and bacterial vaginosis associated bacteria and their association with non-gonococcal urethritis in men. 61
30946763 2019
84
Orogenital Transmission of Neisseria meningitidis Causing Acute Urethritis in Men Who Have Sex with Men. 61
30561300 2019
85
Is the Current Classification of Urethritis as Gonococcal or Nongonoccal Becoming Obsolete? 61
30503160 2019
86
Clinical, histopathologic, cystoscopic, and fluorescence in situ hybridization analysis of proliferative urethritis in 22 dogs. 61
30516855 2019
87
Management of Urethritis: Is It Still the Time for Empirical Antibiotic Treatments? 61
30318465 2019
88
Urethral cavernous hemangioma: a highly misdiagnosed disease (a case report of two patients and literature review). 61
30704439 2019
89
Is urethral microscopy useful in symptomatic male patients without urethral discharge? 61
30170534 2019
90
Applications of genomics to slow the spread of multidrug-resistant Neisseria gonorrhoeae. 61
29876934 2019
91
Experimental Human Infection with Neisseria gonorrhoeae. 61
31119638 2019
92
How to Identify Exposed Women Who Are Infected with Neisseria gonorrhoeae. 61
31119615 2019
93
Mechanistic Insight Into the Activation of the NLRP3 Inflammasome by Neisseria gonorrhoeae in Macrophages. 61
31417575 2019
94
Chlamydia trachomatis screening in urine among asymptomatic men attending an STI clinic in Paris: a cross-sectional study. 61
30621621 2019
95
Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non-pregnant women. 61
30682211 2019
96
TLR3 deficiency exacerbates the loss of epithelial barrier function during genital tract Chlamydia muridarum infection. 61
30625140 2019
97
Survey of Obstetrician-gynecologists in the United States About Trichomoniasis, 2016. 61
29994936 2019
98
Microscopy of Gram-stained urethral smear in the diagnosis of urethritis: Which threshold value should be selected? 61
30238498 2018
99
Acute kidney injury caused by systemic Neisseria gonorrhoeae infection after successful kidney transplantation. 61
30171774 2018
100
Spectrum of parasitic infections in centrifuged urine sediments from a newly developed tertiary care centre in Central India. 61
30538361 2018
101
[Current diagnosis and treatment of sexually transmitted infections]. 61
30377706 2018
102
Looking at the positives: proactive management of STIs in people with HIV. 61
30577866 2018
103
Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women? - a position statement from the European STI Guidelines Editorial Board. 61
29924422 2018
104
Principles and practice of high-dose rate penile brachytherapy: Planning and delivery techniques. 61
29890234 2018
105
Surveillance of the prevalence of macrolide and/or fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Japan. 61
30190106 2018
106
Multidrug-resistant Neisseria gonorrhoeae isolate, belonging to the internationally spreading Japanese FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, Ireland, August 2018. 61
30482267 2018
107
Prostatitis, other genitourinary infections and prostate cancer risk: Influence of non-steroidal anti-inflammatory drugs? Results from the EPICAP study. 61
29696626 2018
108
The demographic and clinical profiles of women presenting with vaginal discharge syndrome at primary care facilities in South Africa: Associations with age and implications for management. 61
30421718 2018
109
Acute and late toxicities in localized prostate cancer patients treated with low-dose 125I brachytherapy (110 Gy) in combination with external beam radiation therapy versus brachytherapy alone (160 Gy). 61
30479615 2018
110
Stricture Urethra in Children: An Indian Perspective. 61
30443113 2018
111
Chlamydia trachomatis asymptomatic urethritis recurrence among males living with HIV-1. 61
30379232 2018
112
Is previous azithromycin treatment associated with azithromycin resistance in Neisseria gonorrhoeae? A cross-sectional study using national surveillance data in England. 61
29511067 2018
113
Risk factors for human papillomavirus detection in urine samples of heterosexual men visiting urological clinics in Japan. 61
29759898 2018
114
Mycoplasma genitalium infections in Cuba: surveillance of urogenital syndromes, 2014-2015. 61
29742999 2018
115
Multi-centric validation of an in-house-developed beacon-based PCR diagnostic assay kit for Chlamydia and Neisseria and portable fluorescence detector. 61
30051801 2018
116
Hyperthyroidism is not a significant risk of benign prostatic hyperplasia: A nationwide population-based study. 61
30278528 2018
117
Isotretinoin-induced urethritis versus non-gonococcal urethritis in a man who has sex with men: an open debate. 61
29512421 2018
118
Sustained influence of infections on prostate-specific antigen concentration: An analysis of changes over 10 years of follow-up. 61
30133756 2018
119
Neisseria meningitidis urethritis: synthesis of published data. 61
29797510 2018
120
Transcriptome Analysis of Neisseria gonorrhoeae during Natural Infection Reveals Differential Expression of Antibiotic Resistance Determinants between Men and Women. 61
29950382 2018
121
Macrolide and fluoroquinolone resistance is uncommon in clinical strains of Chlamydia trachomatis. 61
29627327 2018
122
Haemophilus parainfluenzae urethritis through orogenital transmission. 61
30623185 2018
123
Defining the Urethritis Syndrome in Men Using Patient Reported Symptoms. 61
29465655 2018
124
Trends in Neisseria gonorrhoeae Antimicrobial Resistance over a Ten-Year Surveillance Period, Johannesburg, South Africa, 2008⁻2017. 61
30002329 2018
125
[Mycoplasma genitalium and male urogenital diseases: An update]. 61
30173450 2018
126
Health-related quality of life and psychosocial impacts of a diagnosis of non-specific genital infection in symptomatic heterosexual men attending UK sexual health clinics: a feasibility study. 61
29960999 2018
127
Alisma canaliculatum ethanol extract suppresses inflammatory responses in LPS-stimulated macrophages, HCl/EtOH-induced gastritis, and DSS-triggered colitis by targeting Src/Syk and TAK1 activities. 61
29574093 2018
128
Prevalence of Mycoplasma genitalium in different population groups: systematic review andmeta-analysis. 61
29440466 2018
129
Highlighting the clinical need for diagnosing Mycoplasma genitalium infection. 61
29431025 2018
130
Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in M. genitalium in Denmark, Norway and Sweden in 2016. 61
28923377 2018
131
[Urology and alternative medicine (1900-1970)]. 61
29616284 2018
132
New Treatment for Urethral Rent in Stallions. 61
30973159 2018
133
A case of non-treated Trichomonas vaginalis infection and severe preterm labor with positive obstetrical outcome. 61
29391293 2018
134
GyrA and/or ParC alterations of Haemophilus influenzae strains isolated from the urethra of men with acute urethritis. 61
29138021 2018
135
Expansion of a urethritis-associated Neisseria meningitidis clade in the United States with concurrent acquisition of N. gonorrhoeae alleles. 61
29499642 2018
136
Prevalence of Mycoplasma genitalium and other sexually-transmitted pathogens among high-risk individuals in Greece. 61